Merrill S. Kies
The University of Texas MD Anderson Cancer Center · 335 works · 23,402 citations · h-index 69
Top works
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck
- Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non-Small-Cell Lung Cancer
- Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results
- Head and Neck Cancers
- Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination
- Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer
- Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab
- Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer
- Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911
- How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?
- Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer
- Concomitant Infusional Paclitaxel and Fluorouracil, Oral Hydroxyurea, and Hyperfractionated Radiation for Locally Advanced Squamous Head and Neck Cancer
- Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin
- Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma
- The Role of Cervical Lymphadenectomy After Aggressive Concomitant Chemoradiotherapy
- Radiation‐induced Xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and management